Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the Detection of Plasmodium Infections in Patients With Symptoms Suggestive of Malaria

NACompletedINTERVENTIONAL
Enrollment

1,023

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

November 17, 2022

Study Completion Date

November 17, 2022

Conditions
Malaria
Interventions
DIAGNOSTIC_TEST

NxTekTM Malaria Pf Plus Rapid Diagnostic Test Device

"NxTekTM Malaria Pf/Pv Plus: A sensitive rapid chromatographic immunoassay for the qualitative detection of histidine-rich protein 2 (HRP2) and Plasmodium lactate dehydrogenase (pLDH) of Plasmodium falciparum(P.f.) on one test line and of pLDH of Plasmodium vivax (P.v.) malaria on a second test line in human whole blood. This test is a lateral flow test for in vitro professional diagnostic use and intended as an aid to early diagnosis of Malaria infection in-patients with clinical symptoms.~NxTekTM Malaria Pf Plus: A sensitive rapid chromatographic immunoassay for the qualitative detection of histidine-rich protein 2 (HRP2) and pLDH on a single test line of Plasmodium falciparum(P.f.) malaria in human whole blood. This test is a lateral flow test for in vitro professional diagnostic use and intended as an aid to early diagnosis of Malaria infection in-patients with clinical symptoms."

Trial Locations (1)

Unknown

Medical Parasitology Research Unit, Aklilu Lemma Institute of Pathobiology (ALIPB), Addis Ababa University (AAU)., Addis Ababa

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Abbott Rapid Dx

INDUSTRY